Ballicules.com

Vortioxetine

TRINTELLIX

What it isSerotonin reuptake inhibitor with additional receptor modulation; depression.

Why this oneEvidence for improving cognitive symptoms of depression, and less sexual dysfunction than an SSRI.

What limits itNausea is dose-related and the commonest reason for stopping. CYP2D6-dependent, and cost is a barrier.

FDA-approved for

FDA label

BOXED WARNING Suicidal thoughts and behaviors in pediatric and young adult patients; not approved for pediatric use
FDA dosingPopulationStartTargetMax
Major depressive disorder (MDD)adult10 mg QD20 mg QD20 mg QD
MDDCYP2D6 poor metabolizers10 mg QD10 mg QD10 mg QD

Renal Undefined

Hepatic Undefined

5 mg/day may be considered for patients who do not tolerate higher doses

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Limited data; third-trimester use may increase risk of PPHN and neonatal complications

Lactation No human milk data; weigh benefits against clinical need

⚠ BOXED WARNING

Cost, est. cash$200–$1,200/month

Generic entry2027 est.

Classes and tags

Clinical profile

Therapeutic safety burden1 / 4
Overdose danger1 / 4
Weight-gain liability1 / 4
Sedation liability1 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk2 / 4

Legacy pregnancy categoryC

Defining liabilityNausea, sexual effects and serotonin toxicity are the principal concerns.

Mechanism of action: Vortioxetine ballicule

Vortioxetine ballicule: receptor binding, kinetics and half-life diagram

Open Vortioxetine in the interactive console ↗

Memory aids: mascots and interaction avatars

Vortioxetine TRINTELLIX mascot mnemonic cartoon
“Trent’s Vortex”
Trent Reznor (Nine Inch Nails)
“serotonergic vortex” of nausea
guitar pick-shaped tablets
“Fight the fog (machine) of depression” → cognitive benefits
Vortioxetine CYP2D6 substrate avatar
CYP2D6 substrate
Vortioxetine CYP3A4 substrate avatar
CYP3A4 substrate

Open Vortioxetine in the interactive console ↗